Literature DB >> 33406582

Prevalence and Risk Factors of Latent Tuberculosis Infection (LTBI) in Patients with Type 2 Diabetes Mellitus (T2DM).

Phan Ai Ping1, Rosnani Zakaria1, Md Asiful Islam2, Lili Husniati Yaacob1, Rosediani Muhamad1, Wan Mohamad Zahiruddin Wan Mohamad3, Harmy Mohamed Yusoff4.   

Abstract

Type 2 diabetes mellitus (T2DM) and tuberculosis (TB) together impose a high disease burden in terms of both mortality and health economics worldwide. The objective of this study was to estimate the prevalence and risk factors of latent TB infection (LTBI) in patients with T2DM in Malaysia. A cross-sectional study was performed, and adult T2DM patients (n = 299) were included. Simple and multiple logistic regression analyses were performed to identify the LTBI-associated risk factors in patients with T2DM. Multiple logistic regression was used to estimate adjusted odds ratios (aOR) and 95% confidence intervals (CIs) between T2DM and LTBI and was adjusted for potential confounders. The prevalence of LTBI in patients with T2DM was 11.4% (95% CI: 8.0-15.0%). There was no significant difference in the socio-demographic characteristics between LTBI and non-LTBI subjects. No significant difference in the smoking status, the duration of smoking, and the duration of T2DM, HbA1c, or treatments was observed. Interestingly, a higher level of education was observed to be associated with a lower prevalence of LTBI in T2DM patients (aOR: 0.08, 95% CI: 0.01-0.70, p = 0.02). Although the prevalence of LTBI in T2DM was low, it is important to screen for it in T2DM patients due to the risk of developing severe active TB.

Entities:  

Keywords:  latent tuberculosis infection; prevalence; risk factors; tuberculin skin test; type 2 diabetes mellitus

Mesh:

Year:  2021        PMID: 33406582      PMCID: PMC7794868          DOI: 10.3390/ijerph18010305

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  24 in total

Review 1.  Latent TB (LTBI) treatment: Challenges in India with an eye on 2025: "To Treat LTBI or not to treat, that is the question".

Authors:  Sanjay Rajpal; V K Arora
Journal:  Indian J Tuberc       Date:  2020-10-01

2.  Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis.

Authors:  Anthony D Harries; Megan B Murray; Christie Y Jeon; Salah-Eddine Ottmani; Knut Lonnroth; Mauricio L Barreto; Nils Billo; Richard Brostrom; Ib Christian Bygbjerg; Susan Fisher-Hoch; Toru Mori; Kaushik Ramaiya; Gojka Roglic; Hanne Strandgaard; Nigel Unwin; Vijay Viswanathan; David Whiting; Anil Kapur
Journal:  Trop Med Int Health       Date:  2010-04-12       Impact factor: 2.622

3.  [Tuberculin test in diabetic patients in a health center].

Authors:  M J Mansilla Bermejo; M J Sanz Gil; P Moraleda Velasco; A Alvárez Prado; J J Carbayo García; F Mata Guijarro
Journal:  Aten Primaria       Date:  1995 Jul-Aug       Impact factor: 1.137

4.  A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements.

Authors:  L Wang; M O Turner; R K Elwood; M Schulzer; J M FitzGerald
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

5.  Type 2 diabetes mellitus coincident with pulmonary or latent tuberculosis results in modulation of adipocytokines.

Authors:  Nathella Pavan Kumar; Dina Nair; V V Banurekha; Chandrakumar Dolla; Paul Kumaran; Rathinam Sridhar; Subash Babu
Journal:  Cytokine       Date:  2016-01-06       Impact factor: 3.861

Review 6.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.

Authors:  Elizabeth L Corbett; Catherine J Watt; Neff Walker; Dermot Maher; Brian G Williams; Mario C Raviglione; Christopher Dye
Journal:  Arch Intern Med       Date:  2003-05-12

7.  Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls.

Authors:  Daniel Faurholt-Jepsen; Martine Grosos Aabye; Andreas Vestergaard Jensen; Nyagosya Range; George Praygod; Kidola Jeremiah; John Changalucha; Maria Faurholt-Jepsen; Lotte Jensen; Signe Marie Jensen; Henrik Krarup; Pernille Ravn; Henrik Friis; Ase Bengård Andersen
Journal:  Scand J Infect Dis       Date:  2014-03-12

Review 8.  The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.

Authors:  Rein M G J Houben; Peter J Dodd
Journal:  PLoS Med       Date:  2016-10-25       Impact factor: 11.069

9.  Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines.

Authors:  Tasnim Hasan; Eric Au; Sharon Chen; Allison Tong; Germaine Wong
Journal:  BMJ Open       Date:  2018-09-12       Impact factor: 2.692

10.  Latent Tuberculosis Infection Treatment Completion while Shifting Prescription from Isoniazid-Only to Rifampicin-Containing Regimens: A Two-Decade Experience in Milan, Italy.

Authors:  Simone Villa; Maurizio Ferrarese; Giovanni Sotgiu; Paola Francesca Castellotti; Laura Saderi; Cecilia Grecchi; Matteo Saporiti; Mario Raviglione; Luigi Ruffo Codecasa
Journal:  J Clin Med       Date:  2019-12-31       Impact factor: 4.241

View more
  2 in total

1.  Prevalence of latent tuberculosis infection among patients with interstitial lung disease requiring immunosuppression.

Authors:  Vitor Loureiro Dias; Karin Mueller Storrer
Journal:  J Bras Pneumol       Date:  2022-03-28       Impact factor: 2.624

2.  Triglyceride Glucose-Body Mass Index and Risk of Incident Type 2 Diabetes Mellitus in Japanese People With Normal Glycemic Level: A Population-Based Longitudinal Cohort Study.

Authors:  Bei Song; Xiaofang Zhao; Tianci Yao; Weilin Lu; Hao Zhang; Ting Liu; Chengyun Liu; Kun Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.